Leukocyte Surface Antigen CD47 Market Competitive Landscape

ha aggiunto una foto Health

2026-07-01 09:37:14

The Leukocyte Surface Antigen CD47 Market features intense competition among global pharmaceutical and biotechnology leaders. Key companies include Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AbbVie, Novartis, Eli Lilly, Merck & Co, Verastem Oncology, and Sorrento Therapeutics. Gilead Sciences strengthened its position through the acquisition of Forty Seven Inc. and subsequent...

0 Commenti 0 condivisioni 27 Views 0 Anteprima